Terms: = Prostate cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7
569 results:
1. Patterns of B-cell lymphocyte expression changes in pre- and post-malignant prostate tissue are associated with prostate cancer progression.
Sadasivan SM; Loveless IM; Chen Y; Gupta NS; Sanii R; Bobbitt KR; Chitale DA; Williamson SR; Rundle AG; Rybicki BA
Cancer Med; 2024 Mar; 13(6):e7118. PubMed ID: 38523528
[TBL] [Abstract] [Full Text] [Related]
2. A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin-induced apoptosis in castration-resistant prostate cancer.
Ye PC; Leu WJ; Yeh TY; Hsu YT; Lin YC; Wei ZY; Chen YC; Chiang YC; Hsu JL; Chan SH; Hsu LC; Chern JW; Yu CW; Guh JH
Prostate; 2024 May; 84(6):605-619. PubMed ID: 38375594
[TBL] [Abstract] [Full Text] [Related]
3. A Machine Learning Method for Predicting Biomarkers Associated with prostate cancer.
Tong Y; Tan Z; Wang P; Gao X
Front Biosci (Landmark Ed); 2023 Dec; 28(12):333. PubMed ID: 38179769
[TBL] [Abstract] [Full Text] [Related]
4. Aloe-Emodin Isolated from
He MT; Nguyen QN; Cho EJ; Kim SH; Park S; Park JY; Lee S; Kang KS
J Diet Suppl; 2024; 21(3):389-407. PubMed ID: 38062982
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
6. Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models.
Li X; Chen Y; Bai L; Zhao R; Wu Y; Xie ZR; Wu JM; Bowen NJ; Danaher A; Cook N; Li D; Qui M; Du Y; Fu H; Osunkoya AO; Kucuk O; Wu D
Br J Cancer; 2023 Sep; 129(5):884-894. PubMed ID: 37474721
[TBL] [Abstract] [Full Text] [Related]
7. SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer.
Zielske SP; Chen W; Ibrahim KG; Cackowski FC
BMC Cancer; 2023 Jul; 23(1):672. PubMed ID: 37464317
[TBL] [Abstract] [Full Text] [Related]
8. Dependency of Tamoxifen Sensitive and Resistant ER
Bhasin S; Dusek C; Peacock JW; Cherkasov A; Wang Y; Gleave M; Ong CJ
Cells; 2023 Jun; 12(13):. PubMed ID: 37443749
[TBL] [Abstract] [Full Text] [Related]
9. CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m
Qi F; Shen W; Wei X; Cheng Y; Xu F; Zheng Y; Li L; Qin C; Li X
Cell Mol Life Sci; 2023 May; 80(6):156. PubMed ID: 37208565
[TBL] [Abstract] [Full Text] [Related]
10. Scaffold hopping of N-benzyl-3,4,5-trimethoxyaniline: 5,6,7-Trimethoxyflavan derivatives as novel potential anticancer agents modulating hippo signaling pathway.
Hassan AHE; Wang CY; Lee HJ; Jung SJ; Kim YJ; Cho SB; Lee CH; Ham G; Oh T; Lee SK; Lee YS
Eur J Med Chem; 2023 Aug; 256():115421. PubMed ID: 37163949
[TBL] [Abstract] [Full Text] [Related]
11. Plexin-B1 Mutation Drives Metastasis in prostate cancer Mouse Models.
Shorning B; Trent N; Griffiths DF; Worzfeld T; Offermanns S; Smalley MJ; Williamson M
Cancer Res Commun; 2023 Mar; 3(3):444-458. PubMed ID: 36936664
[TBL] [Abstract] [Full Text] [Related]
12. Infiltrating immune cells in prostate cancer tissue after androgen deprivation and radiotherapy.
Erlandsson A; Lundholm M; Watz J; Bergh A; Petrova E; Alamdari F; Helleday T; Davidsson S; Andren O; Tarish F
Int J Immunopathol Pharmacol; 2023; 37():3946320231158025. PubMed ID: 36880147
[TBL] [Abstract] [Full Text] [Related]
13. NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation.
Zhang P; Chen L; Zhou F; He Z; Wang G; Luo Y
Cell Death Dis; 2023 Feb; 14(2):159. PubMed ID: 36841806
[TBL] [Abstract] [Full Text] [Related]
14. The added value of AI-based computer-aided diagnosis in classification of cancer at prostate MRI.
Liu G; Pan S; Zhao R; Zhou H; Chen J; Zhou X; Xu J; Zhou Y; Xue W; Wu G
Eur Radiol; 2023 Jul; 33(7):5118-5130. PubMed ID: 36725719
[TBL] [Abstract] [Full Text] [Related]
15. LQB-118 Suppresses Migration and Invasion of prostate cancer Cells by Modulating the Akt/GSK3β Pathway and MMP-9/Reck Gene Expression.
Martino T; DE Bem GF; Santos SVM; Coelho MGP; Resende AC; Netto C; Costa PRR; Justo G; Sabino KCC
Anticancer Res; 2023 Jan; 43(1):359-367. PubMed ID: 36585169
[TBL] [Abstract] [Full Text] [Related]
16. Comparative Prospective and Longitudinal Analysis on the Platelet-to-Lymphocyte, Neutrophil-to-Lymphocyte, and Albumin-to-Globulin Ratio in Patients with Non-Metastatic and Metastatic prostate cancer.
Salciccia S; Frisenda M; Bevilacqua G; Viscuso P; Casale P; De Berardinis E; Di Pierro GB; Cattarino S; Giorgino G; Rosati D; Del Giudice F; Carbone A; Pastore A; Chung BI; Eisenberg ML; Autorino R; Crivellaro S; Forte F; Sciarra A; Mariotti G; Gentilucci A
Curr Oncol; 2022 Dec; 29(12):9474-9500. PubMed ID: 36547159
[TBL] [Abstract] [Full Text] [Related]
17. The Role of Radiolabeled Monoclonal Antibodies in cancer Imaging and ADC Treatment.
Martiniova L; Zielinski RJ; Lin M; DePalatis L; Ravizzini GC
Cancer J; 2022 Nov-Dec 01; 28(6):446-453. PubMed ID: 36383907
[TBL] [Abstract] [Full Text] [Related]
18. HMGB1 promotes the development of castration‑resistant prostate cancer by regulating androgen receptor activation.
Chen J; Xu D; Wang T; Yang Z; Yang Y; He K; Zhao L
Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36129149
[TBL] [Abstract] [Full Text] [Related]
19. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
[TBL] [Abstract] [Full Text] [Related]
20. Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of prostate cancer through PI3K/AKT/NF-
Lei Y; Chan M; Liu H; Lyu W; Chen L; Zhong Y; Gan H; Wang M; Qi M; Guo Y; Liu J; Zhang E
Dis Markers; 2022; 2022():4399334. PubMed ID: 35899176
[TBL] [Abstract] [Full Text] [Related]
[Next]
